Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tezspire soluzione iniettabile in siringa preriempita
astrazeneca ag - tezepelumabum - soluzione iniettabile in siringa preriempita - tezepelumabum 210 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum q.s. ad ph, aqua ad iniectabile, ad solutionem pro 1.91 ml. - zusatztherapie bei schwerem asthma - biotechnologika
Unione Europea -
italiano -
EMA (European Medicines Agency)
tezspire
astrazeneca ab - tezepelumab - asma - farmaci per le malattie respiratorie ostruttive, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tezspire 110 mg/ml soluzione iniettabile in penna pre-riempita
astrazeneca ag - tezepelumabum - soluzione iniettabile in penna pre-riempita - tezepelumabum 210 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum q.s. ad ph, aqua ad iniectabile, ad solutionem pro 1.91 ml. - zusatztherapie bei schwerem asthma - biotechnologika